ID   SCCNC2
AC   CVCL_X157
DR   Cosmic; 2614474
DR   GEO; GSM1377035
DR   Wikidata; Q54952387
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
RX   PubMed=24662767; DOI=10.1038/jid.2014.154; PMCID=PMC4753672;
RA   South A.P., Purdie K.J., Watt S.A., Haldenby S., den Breems N.Y.,
RA   Dimon M., Arron S.T., Kluk M.J., Aster J.C., McHugh A., Xue D.J.,
RA   Dayal J.H.S., Robinson K.S., Rizvi S.M.H., Proby C.M., Harwood C.A.,
RA   Leigh I.M.;
RT   "NOTCH1 mutations occur early during cutaneous squamous cell
RT   carcinogenesis.";
RL   J. Invest. Dermatol. 134:2630-2638(2014).
//
RX   PubMed=24816148; DOI=10.1038/srep04925; PMCID=PMC4017217;
RA   Garcia-Inclan C., Lopez-Hernandez A., Alonso-Guervos M., Allonca E.,
RA   Potes S., Melon S., Lopez F., Llorente J.L., Hermsen M.A.J.A.;
RT   "Establishment and genetic characterization of six unique tumor cell
RT   lines as preclinical models for sinonasal squamous cell carcinoma.";
RL   Sci. Rep. 4:4925.1-4925.12(2014).
//